S. Ratcliffe

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex^®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

Alena Novotná, Jan Mareš, S. Ratcliffe et al. · European Journal of Neurology · 2011 · 464 citations

Medicine, Neurology, Pharmacology +17

Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis

Christine Collin, Paul Davies, I. K. Mutiboko et al. · European Journal of Neurology · 2007 · 382 citations

Pharmacy, Neurology, Pharmacotherapy +16

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

Richard Langford, Jan Mareš, Alena Novotná et al. · Journal of Neurology · 2012 · 297 citations

Medicine, Pharmacology, Pharmacotherapy +16

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

Christine Collin, Edvard Ehler, G Waberzinek et al. · Neurological Research · 2010 · 278 citations

Pharmacy, Neurology, Pharmacotherapy +16

Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study

Khalid Jadoon, S. Ratcliffe, David A. Barrett et al. · Diabetes Care · 2016 · 254 citations · Full text

Medicine, Internal Medicine, Pharmacology +17